Craig C Hofmeister Selected Research

IPH-2101

9/2015	A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.
11/2012	A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.
12/2011	IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Craig C Hofmeister Research Topics

Disease

61	Multiple Myeloma 01/2023 - 03/2008
18	Neoplasms (Cancer) 01/2023 - 09/2010
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 06/2004
7	Lymphoma (Lymphomas) 01/2021 - 05/2009
7	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 11/2005
4	Neutropenia 01/2020 - 09/2011
4	Disease Progression 06/2019 - 05/2012
3	Fatigue 01/2020 - 09/2011
2	Stomatitis 01/2022 - 11/2005
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2021 - 01/2018
2	Meningioma (Meningiomas) 10/2021 - 01/2021
2	Neurofibromatoses (Neurofibromatosis) 10/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2020 - 09/2017
2	Vomiting 01/2020 - 11/2014
2	Diarrhea 01/2020 - 02/2014
2	Nausea 01/2020 - 11/2014
2	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2013
2	Amyloidosis 06/2014 - 08/2012
1	Cytokine Release Syndrome 12/2023
1	Breakthrough Infections 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Diabetes Mellitus 01/2023
1	Obesity 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Acoustic Neuroma (Acoustic Neurinoma) 10/2021
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 10/2021
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2021
1	Neurilemmoma (Schwannoma) 01/2021
1	Pain (Aches) 10/2020
1	Smoldering Multiple Myeloma 01/2020
1	Hyponatremia 01/2020

Drug/Important Bio-Agent (IBA)

17	Lenalidomide (CC 5013)FDA Link 12/2022 - 10/2008
11	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 11/2014
10	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022 - 07/2011
6	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2014
5	Bortezomib (Velcade)FDA Link 01/2023 - 07/2011
5	daratumumabIBA 01/2021 - 12/2016
5	SteroidsIBA 10/2017 - 07/2008
4	Histone Deacetylase InhibitorsIBA 10/2021 - 01/2016
4	Proteasome InhibitorsIBA 12/2020 - 01/2016
4	MicroRNAs (MicroRNA)IBA 01/2017 - 05/2013
4	LigandsIBA 09/2015 - 09/2010
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2014
3	ixazomibIBA 12/2022 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 12/2020 - 11/2012
3	Vorinostat FDA Link 01/2020 - 04/2015
3	IPH-2101IBA 09/2015 - 12/2011
2	tocilizumab (atlizumab)FDA Link 12/2023 - 01/2016
2	Cytochrome P-450 CYP3AIBA 01/2023 - 01/2023
2	VaccinesIBA 01/2023 - 10/2022
2	AntigensIBA 01/2023 - 03/2016
2	Thalidomide (Thalomid)FDA Link 01/2023 - 10/2012
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2014
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2020 - 03/2016
2	selinexorIBA 01/2020 - 01/2018
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020 - 11/2005
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2018 - 12/2017
2	Capsid Proteins (Capsid Protein)IBA 02/2018 - 12/2014
2	Caspase 3 (Caspase-3)IBA 02/2018 - 12/2014
2	elotuzumabIBA 12/2016 - 12/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 03/2008
2	Junctional Adhesion MoleculesIBA 01/2016 - 12/2014
2	KIR ReceptorsIBA 09/2015 - 12/2011
2	pomalidomideIBA 03/2014 - 01/2014
2	alvocidib (flavopiridol)IBA 02/2014 - 10/2008
2	Monoclonal AntibodiesIBA 12/2013 - 07/2008
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	talazoparibIBA 01/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	olaparibIBA 01/2023
1	Pregabalin (Lyrica)FDA Link 01/2022
1	EltanexorIBA 01/2022
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2022
1	Immunoglobulin M (IgM)IBA 11/2021
1	venetoclaxIBA 01/2021
1	N 30IBA 01/2021
1	trans-crotonin (CTN)IBA 01/2021
1	ChromatinIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 10/2020
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2020
1	CannabinoidsIBA 01/2020
1	Thrombopoietin ReceptorsIBA 01/2020
1	Olanzapine (Zyprexa)FDA Link 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	Serotonin 5-HT3 Receptor AntagonistsIBA 01/2020
1	MegestrolIBA 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020

Therapy/Procedure

25	Therapeutics 01/2023 - 06/2004
8	Stem Cell Transplantation 01/2020 - 07/2008
6	Hematopoietic Stem Cell Transplantation 01/2023 - 12/2005
5	Drug Therapy (Chemotherapy) 10/2019 - 11/2005
4	Transplantation 06/2019 - 06/2004
2	Drug Tapering 01/2023 - 08/2013
2	Cell Transplantation 10/2019 - 01/2016
1	Immunotherapy 01/2023
1	Pain Management 10/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2020